Ongoing studies will determine whether B-1 cells shape broader autoantibody profiles and modulate CD8+ T cell activation in the Sle1.Sle2.Sle3 lupus model as they do in Lyn-/- mice. The gene discussed is CD8A; the disease is systemic lupus erythematosus.